Renata Reports 55% Profit Increase
Renata PLC reported significant growth in fiscal year 2023-24, with revenue increasing 14% year-on-year to Tk 3,771 crore and profit…
Renata Reports 55% Profit Increase
Please Subscribe to view full content
Renata Gets EU Approval for Cabergoline 0.5 mg Tablet
Please Subscribe to view full content
Renata Gets EU Approval for Cabergoline 0.5 mg Tablet
Renata PLC, a publicly traded pharmaceutical company, has received European approval to market Cabergoline 0.5 mg tablets for treating hyperprolactinemia…
IFC to Provide $60 Million Loan to Renata
Renata PLC, a leading pharmaceutical company in Bangladesh, plans to secure a $60 million loan from the International Finance Corporation…
IFC to Provide $60 Million Loan to Renata
Please Subscribe to view full content
Stock Market Peaks in Two Months on Linde and Renata Surge
Bangladesh’s stock market surged 1.6%, led by gains in blue-chip firms like Linde Bangladesh and Renata PLC. The DSEX index…
Stock Market Peaks in Two Months on Linde and Renata Surge
Please Subscribe to view full content
Renata Ships £1,50,000 Terbinafine to UK
Please Subscribe to view full content
Renata Ships £1,50,000 Terbinafine to UK
Renata PLC has shipped its first batch of 250 mg Terbinafine tablets, valued at £1,50,000, to the UK market. The…